|
시장보고서
상품코드
2027554
의약품 포장 : 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)Pharmaceutical Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 의약품 포장 시장은 2025년에 1,726억 달러로 평가되었고, 2035년까지 연평균 복합 성장률(CAGR) 15.9%를 나타내 7,446억 달러에 이를 것으로 추정되고 있습니다.
시장 확대는 고령화 및 만성질환 증가로 인한 의약품 수요 증가에 따른 시장 확대가 주도하고 있습니다. 이러한 변화로 인해 의약품의 품질을 유지하고 공급망 전반에 걸쳐 안전성을 보장하는 신뢰할 수 있는 고성능 포장 솔루션에 대한 요구가 증가하고 있습니다. 각 제조업체들은 제품의 안정성을 높이고 유통기한을 연장하며 치료 효과를 유지하기 위해 다양한 소재를 이용한 포장 형태 개발을 진행하고 있습니다. 특히 의약품 생산량 증가에 대응하기 위해 내구성이 뛰어나고 화학적으로 안정된 용기 개발이 주목받고 있습니다. 가볍고 견고한 소재의 혁신으로 규제 요건을 충족하면서 포장 성능을 향상시켰습니다. 동시에 의약품 안전 및 품질 보증에 대한 엄격한 규정 준수 요구 사항은 첨단 포장 기술의 채택을 촉진하고 있습니다. 복잡한 제제 파이프라인 증가는 고정밀, 무균 및 보호 기능을 갖춘 포장 시스템에 대한 수요를 더욱 증가시키고 있습니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 개시 연도 시장 규모 | 1,726억 달러 |
| 예측액 | 7,446억 달러 |
| CAGR | 15.9% |
2025년에는 1차 포장 부문이 시장 점유율의 70.4%를 차지했으며, 이는 제품을 직접적으로 포장하고 보호하는 데 있어 중요한 역할을 반영합니다. 이 부문의 성장은 고도의 무균성, 화학적 안정성 및 오염 제어가 필요한 의약품 형태에 대한 수요 증가에 힘입어 성장세를 보이고 있습니다. 의약품과 직접 접촉하도록 설계된 포장 솔루션은 제품의 무결성을 유지하고 안전성을 보장하며 엄격한 규정 준수 기준을 충족하는 데 필수적입니다. 장벽 기술의 지속적인 발전과 즉시 사용 가능한 형태에 대한 선호도가 높아짐에 따라 이 부문의 선도적 입지를 더욱 공고히 하고 있습니다. 효율적이고 안전하며 확장 가능한 포장 솔루션에 대한 요구는 이 카테고리의 혁신을 계속 주도하고 있습니다.
경질 포장 부문은 신뢰성, 내구성 및 강력한 보호 능력에 힘입어 2025년 56.5%의 점유율을 차지했습니다. 이 부문은 구조적 무결성과 외부 요인에 대한 내성이 요구되는 의약품 포장에 널리 사용되고 있다는 점에서 수혜를 받고 있습니다. 경질 포장 솔루션은 보호 성능 향상, 유통기한 연장, 변조 방지 기능을 제공하여 제품의 안전과 규정 준수를 유지하는 데 필수적입니다. 또한, 의약품 제조 및 유통 프로세스 전반의 효율성을 향상시키는 프리필드(prefilled) 및 레디투유스(ready-to-use) 형태로의 전환이 진행되면서 이 부문 수요를 더욱 촉진하고 있습니다.
북미의 의약품 포장 시장은 고품질 및 규제 준수 포장 솔루션에 대한 강력한 수요에 힘입어 2025년 35.3%의 점유율을 차지했습니다. 이 지역에서는 의약품의 보호를 강화하고 무균 상태를 유지하며 환자의 안전을 보장하기 위해 고안된 첨단 재료와 기술의 채택이 증가하고 있습니다. 특히 복잡한 제형의 의약품 생산 증가는 고성능 포장 시스템에 대한 수요를 주도하고 있습니다. 또한, 규제 프레임워크와 지속가능성에 대한 노력은 혁신적이고 친환경적인 포장재 사용을 촉진하고 있습니다. 포장 기술 혁신과 인프라에 대한 지속적인 투자가 이 지역의 꾸준한 시장 확대를 뒷받침하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추산 및 예측 : 포장 유형별(2022-2035년)
제6장 시장 추산 및 예측 : 포장 형태별(2022-2035년)
제7장 시장 추산 및 예측 : 소재 유형별(2022-2035년)
제8장 시장 추산 및 예측 : 기능별(2022-2035년)
제9장 시장 추산 및 예측 : 제형별(2022-2035년)
제10장 시장 추산 및 예측 : 최종 사용자별(2022-2035년)
제11장 시장 추산 및 예측 : 지역별(2022-2035년)
제12장 기업 개요
KTH 26.05.20The Global Pharmaceutical Packaging Market was valued at USD 172.6 billion in 2025 and is estimated to grow at a CAGR of 15.9% to reach USD 744.6 billion by 2035.
Market expansion is being fueled by the rising demand for pharmaceutical products, supported by a growing aging population and the increasing incidence of long-term health conditions. This shift is accelerating the need for reliable, high-performance packaging solutions that preserve drug quality and ensure safety throughout the supply chain. Manufacturers are advancing packaging formats across multiple material types to enhance product stability, extend shelf life, and maintain therapeutic effectiveness. Increasing attention is being directed toward the development of durable and chemically stable containers, particularly in response to rising pharmaceutical production volumes. Innovation in lightweight and resilient materials is improving packaging performance while aligning with regulatory expectations. At the same time, strict compliance requirements related to drug safety and quality assurance are encouraging the adoption of advanced packaging technologies. The growing pipeline of complex drug formulations is further reinforcing the demand for high-precision, sterile, and protective packaging systems.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $172.6 Billion |
| Forecast Value | $744.6 Billion |
| CAGR | 15.9% |
The primary packaging segment accounted for 70.4% share in 2025, reflecting its critical role in direct product containment and protection. Growth within this segment is supported by increasing demand for drug formats that require high levels of sterility, chemical stability, and contamination control. Packaging solutions designed for direct contact with pharmaceutical products are essential in maintaining integrity, ensuring safety, and meeting stringent compliance standards. Continued advancements in barrier technologies and the increasing preference for ready-to-use formats are further strengthening the segment's leading position. The need for efficient, safe, and scalable packaging solutions continues to drive innovation in this category.
The rigid packaging segment captured 56.5% share in 2025, driven by its reliability, durability, and strong protective capabilities. This segment benefits from widespread use in packaging pharmaceutical formulations that require structural integrity and resistance to external factors. Rigid packaging solutions provide enhanced protection, extended shelf life, and tamper-evident features, making them essential for maintaining product safety and regulatory compliance. The growing shift toward prefilled and ready-to-use formats is further reinforcing demand within this segment, as these solutions improve efficiency across pharmaceutical manufacturing and distribution processes.
North America Pharmaceutical Packaging Market held a 35.3% share in 2025, supported by strong demand for high-quality and compliant packaging solutions. The region is witnessing increasing adoption of advanced materials and technologies designed to enhance drug protection, maintain sterility, and ensure patient safety. Rising pharmaceutical production, particularly for complex drug formulations, is driving demand for high-performance packaging systems. Regulatory frameworks and sustainability initiatives are also encouraging the use of innovative and environmentally responsible packaging materials. Continued investment in packaging innovation and infrastructure is supporting the region's steady market expansion.
Key companies operating in the Global Pharmaceutical Packaging Market include Alpla Group, Amcor plc, AptarGroup, Inc., Becton, Dickinson and Company (BD), Bormioli Pharma, CCL Industries Inc., Comar LLC, Datwyler Holding Inc., Gerresheimer AG, Huhtamaki Oyj, Nipro Corporation, Origin Pharma Packaging, Schott AG, SCHOTT Kaisha Private Limited, SGD Pharma, Stevanato Group S.p.A., and West Pharmaceutical Services, Inc. Companies in the Pharmaceutical Packaging Market are strengthening their market position through a combination of innovation, strategic expansion, and operational efficiency improvements. Industry participants are investing heavily in advanced packaging technologies that enhance product protection, sterility, and compliance with evolving regulatory standards. Organizations are expanding production capacities and upgrading manufacturing facilities to meet rising global demand. Strategic collaborations and partnerships are being pursued to improve technological capabilities and broaden geographic reach. Companies are also focusing on sustainable packaging solutions, incorporating recyclable materials and environmentally responsible processes to align with regulatory and consumer expectations.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis, 2022 - 2035
- 2.2 Key market trends
- 2.2.1 Packaging type trends
- 2.2.2 Packaging Format trends
- 2.2.3 Material type trends
- 2.2.4 Functionality trends
- 2.2.5 Drug Form trends
- 2.2.6 End-User trends
- 2.2.7 Regional trends
- 2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Cost structure
- 3.1.4 Value addition at each stage
- 3.1.5 Factor affecting the value chain
- 3.1.6 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Stringent regulations on drug safety
- 3.2.1.2 Aging population and chronic disease
- 3.2.1.3 Rising global pharmaceutical demand
- 3.2.1.4 Technological advancement in packaging
- 3.2.1.5 Preference for ready to use packaging
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Material fragility and handling risks
- 3.2.2.2 High production costs
- 3.2.3 Market opportunities
- 3.2.3.1 Adoption of ready-to-use packaging
- 3.2.3.2 Sustainable and eco-friendly packaging solutions
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
- 3.7 Technology and Innovation landscape
- 3.7.1 Current technological trends
- 3.7.2 Emerging technologies
- 3.8 Price trends
- 3.8.1 By region
- 3.8.2 By product
- 3.9 Pricing Strategies
- 3.10 Emerging Business Models
- 3.11 Compliance Requirements
- 3.12 Patent and IP analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 Latin America
- 4.2.1.5 Middle East & Africa
- 4.2.2 Market concentration analysis
- 4.2.1 By region
- 4.3 Competitive benchmarking of key players
- 4.3.1 Financial performance comparison
- 4.3.1.1 Revenue
- 4.3.1.2 Profit margin
- 4.3.1.3 R&D
- 4.3.2 Product portfolio comparison
- 4.3.2.1 Product range breadth
- 4.3.2.2 Technology
- 4.3.2.3 Innovation
- 4.3.3 Geographic presence comparison
- 4.3.3.1 Global footprint analysis
- 4.3.3.2 Service network coverage
- 4.3.3.3 Market penetration by region
- 4.3.4 Competitive positioning matrix
- 4.3.4.1 Leaders
- 4.3.4.2 Challengers
- 4.3.4.3 Followers
- 4.3.4.4 Niche players
- 4.3.1 Financial performance comparison
- 4.4 Key developments
- 4.4.1 Mergers and acquisitions
- 4.4.2 Partnerships and collaborations
- 4.4.3 Technological advancements
- 4.4.4 Expansion and investment strategies
- 4.4.5 Digital transformation initiatives
- 4.5 Emerging/ startup competitors landscape
Chapter 5 Market Estimates and Forecast, By Packaging Type, 2022 - 2035 (USD Million & Kilo Tons)
- 5.1 Key trends
- 5.2 Primary packaging
- 5.2.1 Blister packs
- 5.2.2 Bottles & containers
- 5.2.3 Vials & ampoules
- 5.2.4 Prefilled syringes & cartridges
- 5.2.5 Pouches & sachets
- 5.2.6 Others
- 5.3 Secondary packaging
- 5.3.1 Cartons & boxes
- 5.3.2 Labels & leaflets
- 5.3.3 Trays
- 5.4 Tertiary packaging
- 5.4.1 Pallets
- 5.4.2 Corrugated boxes
- 5.4.3 Stretch wrap & shrink film
Chapter 6 Market Estimates and Forecast, By Packaging Format, 2022 - 2035 (USD Million & Kilo Tons)
- 6.1 Key trends
- 6.2 Rigid packaging
- 6.3 Semi-rigid packaging
- 6.4 Flexible packaging
Chapter 7 Market Estimates and Forecast, By Material Type, 2022 - 2035 (USD Million & Kilo Tons)
- 7.1 Key trends
- 7.2 Plastics
- 7.2.1 HDPE
- 7.2.2 PET
- 7.2.3 PP
- 7.2.4 PE
- 7.2.5 Others
- 7.3 Glass
- 7.4 Aluminum
- 7.5 Paper & paperboard
- 7.6 Others
Chapter 8 Market Estimates and Forecast, By Functionality, 2022 - 2035 (USD Million & Kilo Tons)
- 8.1 Key trends
- 8.2 Conventional packaging
- 8.3 Sterile packaging
- 8.4 Child-resistant & tamper-evident packaging
- 8.5 Serialization-enabled packaging
- 8.6 Temperature-controlled packaging (Cold-Chain)
Chapter 9 Market Estimates and Forecast, By Drug Form, 2022 - 2035 (USD Million & Kilo Tons)
- 9.1 Key trends
- 9.2 Solid dosage
- 9.3 Liquid/injectable
- 9.4 Biologics & biosimilars
- 9.5 Dermal & topical
- 9.6 Ophthalmic
- 9.7 Pulmonary/inhalation
- 9.8 Others
Chapter 10 Market Estimates and Forecast, By End User, 2022 - 2035 (USD Million & Kilo Tons)
- 10.1 Key trends
- 10.2 Pharmaceutical manufacturers
- 10.3 Contract manufacturing
- 10.4 Hospitals & healthcare facilities
- 10.5 Retail pharmacies
Chapter 11 Market Estimates and Forecast, By Region, 2022 - 2035 (USD Million & Kilo Tons)
- 11.1 Key trends
- 11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Spain
- 11.3.5 Italy
- 11.3.6 Russia
- 11.4 Asia Pacific
- 11.4.1 China
- 11.4.2 India
- 11.4.3 Japan
- 11.4.4 Australia
- 11.4.5 South Korea
- 11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Argentina
- 11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 UAE
Chapter 12 Company Profiles
- 12.1 Global Players:
- 12.1.1 Amcor plc
- 12.1.2 Gerresheimer AG
- 12.1.3 Schott AG
- 12.1.4 West Pharmaceutical Services, Inc.
- 12.1.5 AptarGroup, Inc.
- 12.1.6 Becton, Dickinson and Company (BD)
- 12.2 Regional Players:
- 12.2.1 Nipro Corporation
- 12.2.2 SGD Pharma
- 12.2.3 Stevanato Group S.p.A.
- 12.2.4 CCL Industries Inc.
- 12.2.5 Origin Pharma Packaging
- 12.2.6 Alpla Group
- 12.3 Local Players:
- 12.3.1 Datwyler Holding Inc.
- 12.3.2 SCHOTT Kaisha Private Limited
- 12.3.3 Bormioli Pharma
- 12.3.4 Comar LLC
- 12.3.5 Huhtamaki Oyj
